Stephen Snell, MD
Otolaryngology · Lawton, OKNPI 1083616247
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,981 of the $3,506 with a category attached, or 85.0%. 25 manufacturers reported payments, led by Harmony Biosciences LLC at 36.6% of the total. 2025 is the largest year on record at $699, 5.3 times the $131 reported in 2019.
Across 141 payments — averaging $24.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$1K
- Jazz Pharmaceuticals Inc.$829
- Avadel CNS Pharmaceuticals, LLC$444
- Optinose US, Inc.$182
- Kaleo, Inc.$133
- Fisher & Paykel Healthcare Inc$82
- plus $554 from 19 others
What the payments were for
- Food & beverage$2,98185%
- Education$52515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 46 | $1,283 |
| Jazz Pharmaceuticals Inc. | 28 | $829 |
| Avadel CNS Pharmaceuticals, LLC | 16 | $444 |
| Optinose US, Inc. | 10 | $182 |
| Kaleo, Inc. | 8 | $133 |
| Fisher & Paykel Healthcare Inc | 3 | $82 |
| GSK | 4 | $73 |
| Stryker | 2 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Sanofi | 2 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| Philips North America LLC | 2 | $32 |
| Eisai Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Alk-abello, Inc | 1 | $26 |
| Tactile Systems Technology Inc | 1 | $19 |
| Greer Laboratories, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Cook Medical LLC | 1 | $17 |
| Preceptis Medical, Inc. | 1 | $16 |
| Omeros Corporation | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Medtronic | 1 | $12 |
How this compares
$3,506 in reported general payments places this provider in the 75th percentile of 109 otolaryngology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 12 | $207,815 |
| Epinephrine | 21 | $3,903 |
| Cevimeline Hcl | 19 | $2,771 |
| SynthroidLevothyroxine Sodium | 20 | $2,499 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,196 |
| Levothyroxine Sodium | 88 | $972 |
| Azelastine Hcl | 15 | $438 |
| Ipratropium Bromide | 23 | $426 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $392 |
| Clonazepam | 56 | $372 |
| Fluconazole | 33 | $371 |
| Azithromycin | 62 | $271 |
| Montelukast Sodium | 24 | $262 |
| Alprazolam | 26 | $253 |
| Eszopiclone | 11 | $248 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Lawton
- Dale SmithLawton$2K
- Kibwei McKinneyOklahoma City$315K
- Richard BakerOklahoma City$17K
- Edward El RassiOklahoma City$13K
- Benjamin CollinsOklahoma City$10K
- Keith ClarkOklahoma City$6K
- Emily WhiteEdmond$6K
- Erica RomanoEdmond$6K
- Rachad MhawejOklahoma City$6K
- Christopher GoffStillwater$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.